Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

APO2L/TRAIL expression in human brain tumors.

M Nakamura1, J Rieger, M Weller

  • 1Unit of Molecular Pathology, International Agency for Research on Cancer, Lyon, France.

Acta Neuropathologica
|January 29, 2000
PubMed
Summary

APO2 ligand (APO2L) induces apoptosis in some brain tumor cells, but expression and sensitivity vary significantly across different tumor types. Medulloblastoma cells showed sensitivity, while neuroblastoma cells were resistant.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measurement of x-ray bremsstrahlung radiation from high energy electrons by stochastic acceleration in Heliotron J.

The Review of scientific instruments·2025
Same author

Correction: Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastoma.

Oncogene·2022
Same author

Epigenetic silencing of miRNA-9 is associated with HES1 oncogenic activity and poor prognosis of medulloblastoma.

British journal of cancer·2013
Same author

Loss of FUBP1 expression in gliomas predicts FUBP1 mutation and is associated with oligodendroglial differentiation, IDH1 mutation and 1p/19q loss of heterozygosity.

Neuropathology and applied neurobiology·2013
Same author

Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastoma.

Oncogene·2011
Same author

Lung fibre burden in lung cancer cases employed in the rock and slag wool industry.

The Annals of occupational hygiene·2005

Area of Science:

  • Oncology
  • Molecular Biology
  • Neuroscience

Background:

  • APO2 ligand (APO2L)/TRAIL is a tumor necrosis factor family member inducing apoptosis.
  • Previous studies showed APO2L expression in gliomas and susceptibility of malignant glioma cells.
  • This study investigates APO2L in medulloblastoma and neuroblastoma.

Purpose of the Study:

  • To determine APO2L expression in medulloblastoma and neuroblastoma cell lines.
  • To assess the sensitivity of these cell lines to APO2L-induced apoptosis.
  • To analyze APO2L expression patterns in various human nervous system tumors.

Main Methods:

  • Immunoblot analysis for APO2L protein expression in cell lines.
  • Viability assays to measure apoptosis induction by soluble APO2L.

Related Experiment Videos

  • Immunohistochemistry to detect APO2L in 115 nervous system tumors.

    • Main Results:

    • APO2L protein detected in one medulloblastoma cell line (DAOY), but not neuroblastoma lines.
    • DAOY cells were sensitive to APO2L-induced apoptosis, enhanced by cycloheximide.
    • Neuroblastoma cell lines were resistant to APO2L.
    • APO2L expression varied across tumor types; strong in pilocytic astrocytomas, absent in oligodendrocytes, present in ependymomas, and in reactive astrocytes of medulloblastomas.

    Conclusions:

    • Significant heterogeneity in APO2L expression and apoptosis susceptibility exists among human brain tumors.
    • APO2L's role and therapeutic potential may differ based on tumor type and cellular context.